{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "KRW", "regularMarketChangePercent": -1.1862396, "regularMarketPrice": 166600.0, "earningsTimestamp": 1683543540, "earningsTimestampStart": 1691060340, "earningsTimestampEnd": 1691409600, "epsCurrentYear": 4234.54, "priceEpsCurrentYear": 39.343117, "sharesOutstanding": 143140000, "fiftyDayAverage": 160414.0, "fiftyDayAverageChange": 6186.0, "fiftyDayAverageChangePercent": 0.03856272, "twoHundredDayAverage": 168528.84, "twoHundredDayAverageChange": -1928.8438, "twoHundredDayAverageChangePercent": -0.011445185, "marketCap": 24133343641600, "sourceInterval": 20, "exchangeDataDelayedBy": 20, "averageAnalystRating": "2.2 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1121731200000, "priceHint": 2, "marketState": "PREPRE", "exchange": "KSC", "shortName": "Celltrion", "longName": "Celltrion, Inc.", "messageBoardId": "finmb_1889807", "exchangeTimezoneName": "Asia/Seoul", "exchangeTimezoneShortName": "KST", "gmtOffSetMilliseconds": 32400000, "market": "kr_market", "esgPopulated": false, "regularMarketChange": -2000.0, "regularMarketTime": 1683873012, "regularMarketDayHigh": 169800.0, "regularMarketDayRange": "166400.0 - 169800.0", "regularMarketDayLow": 166400.0, "regularMarketVolume": 301870, "regularMarketPreviousClose": 168600.0, "bid": 166600.0, "ask": 166700.0, "bidSize": 0, "askSize": 0, "fullExchangeName": "KSE", "financialCurrency": "KRW", "regularMarketOpen": 167800.0, "averageDailyVolume3Month": 511456, "averageDailyVolume10Day": 457558, "fiftyTwoWeekLowChange": 32946.156, "fiftyTwoWeekLowChangePercent": 0.24650362, "fiftyTwoWeekRange": "133653.84 - 206730.77", "fiftyTwoWeekHighChange": -40130.766, "fiftyTwoWeekHighChangePercent": -0.19412091, "fiftyTwoWeekLow": 133653.84, "fiftyTwoWeekHigh": 206730.77, "symbol": "068270.KS"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "23 Academy-ro", "address2": "Yeonsu-gu", "city": "Incheon", "country": "South Korea", "phone": "82 3 2850 5000", "website": "https://www.celltrion.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Celltrion, Inc., together with its subsidiaries, develops and produces therapeutics based on proteins including oncology treatment drugs in South Korea. The company markets bio pharmaceuticals; generic pharmaceuticals; covid-19 test kits. Its antibody biosimilar pipeline includes CT-P39 for the treatment of asthma and urticaria that is in phase 3 clinical trial; CT-P17 for the treatment of autoimmune diseases which is in phase 3 clinical trial; CT-P16 for the treatment of non-small cell lung cancer and colon cancer that is in phase 3 clinical trial; CT-P41 for the treatment of osteoporosis and bone loss, which is in phase 3 clinical trial; CT-P43 for the treatment of psoriasis, crohn's disease, and ulcerative colitis that is in phase 3 clinical trial; CT-P42 for the treatment of diabetic macular edema, which is in phase 3 clinical trial; CT-P47 for the treatment of rheumatoid arthritis, which is in phase 3 clinical trial; CT-P27 for the treatment of pandemic/seasonal influenza that is in phase 2 clinical trial; and CT-G20 for the treatment of Cardiomyopathy that is in phase 1 clinical trial. The company was founded in 2002 and is headquartered in Incheon, South Korea.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Hyong-Gi  Kim", "age": 57, "title": "CEO & Internal Director", "yearBorn": 1965, "fiscalYear": 2011, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Woo-Sung  Kee", "age": 61, "title": "CEO & Internal Director", "yearBorn": 1961, "fiscalYear": 2011, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Stephen  Yeum", "title": "Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Min-Cheol  Shin", "age": 51, "title": "Director of Fin.", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ji-Hoon  Choi", "age": 51, "title": "Director of Legal Affairs", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 2, "boardRisk": 3, "compensationRisk": 1, "shareHolderRightsRisk": 8, "overallRisk": 3, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1325289600, "maxAge": 86400}}], "error": null}}